Skip to main content

This website uses cookies to ensure you get the best experience.

TFS HealthScience and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best experience of it. If you consent to it, we will also use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking “Manage cookies” at the bottom of each website page.

Grow Your Career at TFS

Science moves forward because people do

Who we are

Nordic roots.A global outlook.

TFS location Drag to explore

Join TFS HealthScience, the Swedish-founded CRO that built Europe’s first FSP model in 1996. Our roots are Nordic: agile, collaborative and trust based. Our outlook is global. At TFS, you contribute to clinical development that patients depend on.

Open roles across our locationsView All Jobs
Stay Connected

Open positions

Live

Find where you could make an impact.

Life at TFS HealthScience

What it’s really like to work here

What you’ll find on the page
Our values
  • Trust
  • Quality
  • Passion
  • Flexibility
Hear it from the people who work here
Marta Mellado, Senior Clinical Research Associate at TFS HealthScience
Working as a Clinical Research Associate at TFS means being part of a fantastic and welcoming team of professionals, something that is particularly hard to find elsewhere.
Marta MelladoSenior Clinical Research Associate
Mario Clementi, Drug Safety Manager at TFS HealthScience
What I like most about TFS is the supportive, empowering culture. It encourages me to take initiative and drive change, and it makes me even more committed to my work and to what we achieve together.
Mario ClementiDrug Safety Manager
EcoVadis Gold, Top 5% — Sustainability Rating, September 2026 SustainabilityEcoVadis Gold 2026, in the top 3% of companies rated

Our History

From local roots to global reach.

  1. 1996

    Company founded

    • TFS is founded in Lund, Sweden.
    • TFS is the first CRO in Europe to establish a Functional Service Provider (FSP) business model.
  2. 2001

    Copenhagen office opens

    TFS opens its office in Copenhagen, Denmark.

  3. 2003

    Phase I at Karolinska

    TFS establishes Phase I operations in an agreement with the Karolinska University Hospital, Stockholm, Sweden, for First-In-Man studies, special patient populations, and PET imaging services.

  4. 2004

    TFS Academy begins

    TFS Academy conducts its first clinical research education courses.

  5. 2005

    Growth in Spain and the UK

    • TFS acquires CDC Clinical Data Care to strengthen regulatory, pharmacovigilance and medical writing services.
    • TFS expands into Spain through the acquisition of Clinical Data Care, Spain.
    • TFS opens its office in Uxbridge, UK.
  6. 2008

    Into Benelux and Germany

    TFS acquires IMRO-TRAMARKO, the first established CRO in the Netherlands and expands operations to Benelux and Germany.

  7. 2012

    Italy and France

    • TFS acquires Dimensione Ricerca S.r.l, the first established CRO in Italy.
    • TFS opens its office in Paris, France.
  8. 2013

    Into the United States

    • TFS acquires Beardsworth Consulting Group in the US, an Oncology and Vaccine niche CRO.
    • TFS acquires cost-efficient EDC solution from SEMCON in Sweden.
    • TFS opens office in Germany.
  9. 2014

    Operations in Canada

    TFS starts operations in Canada.

  10. 2015

    Ratos takes a majority stake

    TFS agrees to divest 60% of shares to Ratos.

  11. 2016

    SCIderm and an innovation award

    • TFS acquires SCIderm, a dermatology specialist CRO and expands operations in Germany.
    • TFS awarded Excellence in innovation at Omnicom Innovation Forum for the development of an in-house Protocol Deviation module.
  12. 2017

    Top Job Seal

    TFS’ Dermatology Team awarded the Top Job Seal for outstanding employer qualities.

  13. 2018

    Planning with Citeline

    TFS strengthens Strategic Planning Capabilities with Citeline.

  14. 2019

    Ratos becomes sole owner

    • Ratos acquires remaining 40% of shares in TFS.
    • TFS joins Medidata Partner Program with Rave EDC accreditation.
  15. 2020

    Veeva and Duke partnerships

    • TFS partners with Veeva to offer safety database solution for its trials.
    • TFS partners with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization’s study portfolio.
  16. 2023

    Appletree, Israel and Lisbon

    • TFS acquires Swiss-based Appletree CI Group, expanding expertise in ophthalmology and medical devices.
    • TFS expands operations in Israel fueled by a formalized agreement with former external partner, GCP Clinical Studies.
    • TFS expands footprint with new office in Lisbon, Portugal.
  17. 2024

    First APAC base, Melbourne

    TFS opens its first APAC operational base in Melbourne, Australia, extending clinical delivery across all business units.

  18. 2025

    Ophthalmology, oncology and net zero

    Ophthalmology and oncology units expand, and TFS commits to science-based net-zero targets validated by SBTi.

  19. 2026

    Latin America and VERIGRAFT

    • TFS expands into Latin America.
    • TFS partners with VERIGRAFT on the pivotal Phase II/III trial of P-TEV for chronic venous insufficiency.
TalentLink

Freelancer or Key Opinion Leader?Join TalentLink.

Register your profile once and our Talent Acquisition team keeps you in view for clinical projects across 40 countries. Nothing is shared with a sponsor until you approve it.

  • Free to join
  • No exclusivity
  • 40 countries
Register your profile

Already working at TFS HealthScience?

Let’s recruit together and find your next colleague.